Aceclofenac

CAS No. 89796-99-6

Aceclofenac( Aceclofenac | YT-919 | YT 919 | YT919 | Airtal | Beofenac )

Catalog No. M16460 CAS No. 89796-99-6

Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Aceclofenac
  • Note
    Research use only, not for human use.
  • Brief Description
    Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac.
  • Description
    Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac. It is used for the relief of pain and inflammation in rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. (In Vitro):Aceclofenac (1-30 μM; 72 hours) significantly decreases interleukin-6 production and fully blocks prostaglandin E2 synthesis by IL-1β- or LPS-stimulated human chondrocytes.Aceclofenac inhibits COX-1 with IC50 values superior to 100 μM, but decreases by 50% COX-2 activity at the concentration of 0.77 μM in the whole blood test.Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.(In Vivo):Aceclofenac exhibits Cmax (4.59 μg/mL) following oral administration (rat 20 mg/kg).Aceclofenac exhibits terminal elimination half-life (rat 3.24 h) due to high plasma clearance (rat 1.10 L/h/kg) following intravenous injection (rat 10 mg/kg).
  • In Vitro
    Aceclofenac (1-30 μM; 72 hours) significantly decreases interleukin-6 production and fully blocks prostaglandin E2 synthesis by IL-1β- or LPS-stimulated human chondrocytes.Aceclofenac inhibits COX-1 with IC50 values superior to 100 μM, but decreases by 50% COX-2 activity at the concentration of 0.77 μM in the whole blood test.Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
  • In Vivo
    Aceclofenac exhibits Cmax (4.59 μg/mL) following oral administration (rat 20 mg/kg).Aceclofenac exhibits terminal elimination half-life (rat 3.24 h) due to high plasma clearance (rat 1.10 L/h/kg) following intravenous injection (rat 10 mg/kg). Animal Model:Male Sprague-Dawley rats weighing 32-340 g Dosage:10 mg/kg for i.v., 20 mg/kg for p.o. (Pharmacokinetic Analysis) Administration:Oral administration and intravenous injection Result:T1/2 (3.24 h), Cmax (4.59 μg/mL for p.o.).
  • Synonyms
    Aceclofenac | YT-919 | YT 919 | YT919 | Airtal | Beofenac
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    89796-99-6
  • Formula Weight
    354.18
  • Molecular Formula
    C16H13Cl2NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(OCC(O)=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
  • Chemical Name
    2-(2-(2-((2,6-dichlorophenyl)amino)phenyl)acetoxy)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ganesh M, et al. Int J Biol Macromol. 2015 Mar;74:310-7.
molnova catalog
related products
  • Ampiroxicam

    The prodrug of piroxicam that is a nonsteroidal anti-inflammatory drug (NSAID).

  • FK 3311

    FK 3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).

  • 2-Amino-5-methyl-3-t...

    It is an organic compunds with molecular fomula C6H6N2S.